These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 27187696)
41. Endothelial glycocalyx: basic science and clinical implications. Pillinger NL; Kam P Anaesth Intensive Care; 2017 May; 45(3):295-307. PubMed ID: 28486888 [TBL] [Abstract][Full Text] [Related]
42. Endothelial barrier reinforcement relies on flow-regulated glycocalyx, a potential therapeutic target. Harding IC; Mitra R; Mensah SA; Nersesyan A; Bal NN; Ebong EE Biorheology; 2019; 56(2-3):131-149. PubMed ID: 30988234 [TBL] [Abstract][Full Text] [Related]
43. Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis. Iba T; Levy JH; Aihara K; Kadota K; Tanaka H; Sato K; Nagaoka I Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375342 [TBL] [Abstract][Full Text] [Related]
44. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Uchimido R; Schmidt EP; Shapiro NI Crit Care; 2019 Jan; 23(1):16. PubMed ID: 30654825 [TBL] [Abstract][Full Text] [Related]
45. Poroelastic theory of transcapillary flow: effects of endothelial glycocalyx deterioration. Speziale S; Sivaloganathan S Microvasc Res; 2009 Dec; 78(3):432-41. PubMed ID: 19664642 [TBL] [Abstract][Full Text] [Related]
55. Like a slippery fish, a little slime is a good thing: the glycocalyx revealed. Biddle C AANA J; 2013 Dec; 81(6):473-80. PubMed ID: 24597010 [TBL] [Abstract][Full Text] [Related]
56. Starling forces that oppose filtration after tissue oncotic pressure is increased. Hu X; Adamson RH; Liu B; Curry FE; Weinbaum S Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1724-36. PubMed ID: 11009460 [TBL] [Abstract][Full Text] [Related]
57. Modelling the glycocalyx-endothelium-erythrocyte interaction in the microcirculation: a computational study. Pontrelli G; Halliday I; Spencer TJ; König CS; Collins MW Comput Methods Biomech Biomed Engin; 2015; 18(4):351-61. PubMed ID: 23734750 [TBL] [Abstract][Full Text] [Related]
58. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. Broekhuizen LN; Mooij HL; Kastelein JJ; Stroes ES; Vink H; Nieuwdorp M Curr Opin Lipidol; 2009 Feb; 20(1):57-62. PubMed ID: 19106708 [TBL] [Abstract][Full Text] [Related]
59. Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier. Abe K; Tanaka J; Mishima K; Iijima T PLoS One; 2021; 16(6):e0252416. PubMed ID: 34086745 [TBL] [Abstract][Full Text] [Related]